Politics, like nature, abhors a vacuum. Witness how the pharmaceutical industry has succeeded in taking advantage of President Donald Trump's failure to do something—anything—about high drug prices.
The Cherokee Nation claims the companies should have prevented rather than profited from the opioid epidemic and the mass distribution of addictive pain pills.
Some ailing veterans can now use their federal healthcare benefits at CVS MinuteClinics to treat minor illnesses and injuries, under a pilot program announced Tuesday by the Department of Veterans Affairs.
PBMs and tech startups are responding to underinsurance and the onslaught of high-deductible health plans by cutting out insurers in the quest to help patients lower their prescription drug costs.
Walgreens and Rite Aid will sell 865 stores to rival retailer Fred's for $950 million, potentially removing the final roadblock thwarting a tie up between the nation's largest and third-largest drugstore chains.
CVS Health is partnering with UnitedHealth's pharmacy-benefit manager business OptumRx in a move that helps the retailer compete with rival drugstore chain Walgreens, which struck a similar deal with OptumRx earlier in the year.
CVS has awarded grants to 20 colleges in the first round of a multiyear effort encourage smoke-free policies on college campuses.
Walgreens Boots Alliance earnings topped $1 billion during the fourth quarter, easily surpassing analyst expectations, but also announced a delay in closing its latest megadeal.
We each got into healthcare to make a difference in the lives of others. As healthcare providers, the most fulfilling days are realized when patients are engaged with their own health and with their caregivers. The more we focus on helping others engage, the more we engage ourselves.
Humana, UnitedHealthcare, WellCare, Blue Cross and Blue Shield of Florida and CVS Health are among those participating in a Medicare Part D model that gives insurers financial incentives to offer innovative programs that encourage patients to take their medications.
Activist investors in for-profit healthcare firms want seasoned leaders—often drawn from the ranks of former leaders of not-for-profit healthcare systems—to sit on their boards and help those firms navigate today's fast-changing reimbursement environment.
A number of insurers, pharmacy benefit managers and technology companies are developing smartphone and computer apps to provide accurate drug-pricing information for patients and physicians.